Literature DB >> 18350623

Over-expressed and truncated midkines promote proliferation of BGC823 cells in vitro and tumor growth in vivo.

Qing-Ling Wang1, Hui Wang, Shu-Li Zhao, Ya-Hong Huang, Ya-Yi Hou.   

Abstract

AIM: To determine whether midkine (MK) and its truncated form (tMK) contribute to gastric tumorigenesis using in vitro and in vivo models.
METHODS: Human MK and tMK plasmids were constructed and expressed in BGC823 (a gastric adenocarcinoma cell line) to investigate the effect of over-expressed MK or tMK on cell growth and turmorigenesis in nude mice.
RESULTS: The growth of MK-transfected or tMK-transfected cells was significantly increased compared with that of the control cells, and tMK-transfected cells grew more rapidly than MK-transfected cells. The number of colony formation of the cells transfected with MK or tMK gene was larger than the control cells. In nude mice injected with MK-transfected or tMK-transfected cells, visible tumor was observed earlier and the tumor tissues were larger in size and weight than in control animals that were injected with cells without the transfection of either genes.
CONCLUSION: Over-expressed MK or tMK can promote human gastric cancer cell growth in vitro and in vivo, and tMK has greater effect than MK. tMK may be a more promising gene therapeutic target compared with MK for treatment of malignant tumors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18350623      PMCID: PMC2700418          DOI: 10.3748/wjg.14.1858

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  33 in total

1.  Identification of metastasis-associated genes in prostate cancer by genetic profiling of human prostate cancer cell lines.

Authors:  Lutz Trojan; Axel Schaaf; Annette Steidler; Markus Haak; Georg Thalmann; Thomas Knoll; Norbert Gretz; Peter Alken; Maurice Stephan Michel
Journal:  Anticancer Res       Date:  2005 Jan-Feb       Impact factor: 2.480

2.  Midkine stimulates Wilms' tumor cell proliferation via its signaling receptor.

Authors:  E A Ratovitski; C R Burrow
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  1997-05       Impact factor: 1.770

3.  Overexpression of Midkine in malignant peripheral nerve sheath tumor cells inhibits apoptosis and increases angiogenic potency.

Authors:  Carsten Friedrich; Nikola Holtkamp; Jindrich Cinatl; Sadatoshi Sakuma; Victor F Mautner; Sven Wellman; Martin Michaelis; Günter Henze; Andreas Kurtz; Pablo Hernáiz Driever
Journal:  Int J Oncol       Date:  2005-11       Impact factor: 5.650

4.  Modulation of biological phenotypes for tumor growth and metastasis by target-specific biological inhibitors in gastric cancer.

Authors:  S Y Rha; S H Noh; T S Kim; N C Yoo; J K Roh; J S Min; B S Kim
Journal:  Int J Mol Med       Date:  1999-08       Impact factor: 4.101

5.  Transiently truncated and differentially regulated expression of midkine during mouse embryogenesis.

Authors:  Qin Chen; Yuanyang Yuan; Shuibin Lin; Youde Chang; Xinming Zhuo; Wei Wei; Ping Tao; Lingjuan Ruan; Qifu Li; Zhixing Li
Journal:  Biochem Biophys Res Commun       Date:  2005-05-20       Impact factor: 3.575

6.  Midkine, a heparin-binding growth factor, produced by the host enhances metastasis of Lewis lung carcinoma cells.

Authors:  Ragaa H M Salama; Hisako Muramatsu; Peng Zou; Minoru Okayama; Takashi Muramatsu
Journal:  Cancer Lett       Date:  2006-02-20       Impact factor: 8.679

7.  Truncated midkine induces transformation of cultured cells and short latency of tumorigenesis in nude mice.

Authors:  Shigenori Nobata; Takao Shinozawa; Akio Sakanishi
Journal:  Cancer Lett       Date:  2005-02-28       Impact factor: 8.679

8.  Serum midkine concentrations and gastric cancer.

Authors:  Yuki Obata; Shogo Kikuchi; Yingsong Lin; Kiyoko Yagyu; Takashi Muramatsu; Hideshi Kumai
Journal:  Cancer Sci       Date:  2005-01       Impact factor: 6.716

9.  [Cloning and expression of truncated Midkine cytokine from gastric carcinogenesis tissue in E. coli].

Authors:  Qing-ling Wang; Ya-hong Huang; Hao Xie; Hui Wang
Journal:  Wei Sheng Yan Jiu       Date:  2005-11

10.  Platelet-derived growth factor-BB, insulin-like growth factor-I, and phorbol ester activate different signaling pathways for stimulation of vascular smooth muscle cell migration.

Authors:  L Pukac; J Huangpu; M J Karnovsky
Journal:  Exp Cell Res       Date:  1998-08-01       Impact factor: 3.905

View more
  6 in total

1.  H. sinensis mycelium inhibits epithelial-mesenchymal transition by inactivating the midkine pathway in pulmonary fibrosis.

Authors:  Li Lu; Haiyan Zhu; Hailin Wang; Huaping Liang; Yayi Hou; Huan Dou
Journal:  Front Med       Date:  2021-04-27       Impact factor: 4.592

2.  Increased serum concentrations of estrogen-induced growth factors Midkine and FGF2 in NF1 patients with plexiform neurofibroma.

Authors:  Isis Atallah; Ana M Cieza Rivera; Octavio M Rivero Lezcano; Laura Tascón-González; Carolina González-Cortés; Cristina Diez Tascón; Tania Fernández-Villa; Vicente Martín
Journal:  Am J Transl Res       Date:  2022-05-15       Impact factor: 3.940

3.  ERβ-mediated estradiol enhances epithelial mesenchymal transition of lung adenocarcinoma through increasing transcription of midkine.

Authors:  Guangfeng Zhao; Yunzhong Nie; Mingming Lv; Lingfang He; Tingting Wang; Yayi Hou
Journal:  Mol Endocrinol       Date:  2012-06-05

4.  A conjugate of an anti-midkine single-chain variable fragment to doxorubicin inhibits tumor growth.

Authors:  Shuli Zhao; Guangfeng Zhao; Hao Xie; Yahong Huang; Yayi Hou
Journal:  Braz J Med Biol Res       Date:  2012-01-26       Impact factor: 2.590

5.  Midkine derived from cancer-associated fibroblasts promotes cisplatin-resistance via up-regulation of the expression of lncRNA ANRIL in tumour cells.

Authors:  Dongya Zhang; Liang Ding; Yi Li; Jing Ren; Guoping Shi; Yong Wang; Shuli Zhao; Yanhong Ni; Yayi Hou
Journal:  Sci Rep       Date:  2017-11-24       Impact factor: 4.379

6.  Serum midkine as non-invasive biomarker for detection and prognosis of non-small cell lung cancer.

Authors:  Tamina Rawnaq-Möllers; Tarik Ghadban; Louisa Stern; Erik Mueller; Eugen Bellon; Matthias Reeh; Rainer Grotelueschen; Cenap Guengoer; Nathaniel Melling; Mara Goetz; Daniel R Perez; Jakob R Izbicki
Journal:  Sci Rep       Date:  2021-07-16       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.